IDG leads $80m Series B round in Chinese biotech firm PTM Biolabs

IDG leads $80m Series B round in Chinese biotech firm PTM Biolabs

Laboratory equipment. Photo: Pixabay

12 November, 2020

biotech IDG Capital proteomics PTM Biolabs

Printed by Unregistered user on Sun, 27 Jul 2025 11:24:31 GMT

Bring stories like this into your inbox every day.

Sign up for our newsletter - The Daily Brief

Subscribe to Newsletter

You may also like

Venture Capital

Chinese biotech firm RecBio raises over $227.4m in Series B round

Venture Capital

China-focused IDG Capital in market for new $550m venture fund

Read more from Greater China

Editor’s Take: The Week That Was—July 21-26

Hong Kong IPO boom triggers price war among banks